newsfilter
← Latest News
GlobeNewswire·

Societal CDMO Reports Fourth Quarter and Full Year 2022 Financial Results

Recorded Q4 Revenue of $24.3 Million, a 9% Increase Compared to Prior Year Period Clinical Trial Materials Development Business Grew by 58% in 2022; Significantly Expanded and Diversified Customer Base Executed